Logos Global Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Logos Global Management’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$44.5M	Buy	+85,000	New	+$40.6M	2.22%	13
2025 Q3	–	Sell	-50,000	Closed	-$15.1M	–	66
2025 Q2	$15.1M	Buy	+50,000	New	+$14.9M	1.67%	21
2023 Q2	–	Sell	-50,000	Closed	-$12.1M	–	57
2023 Q1	$12.1M	Sell	50,000 -10,000	-17%	-$2.72M	1.73%	24
2022 Q4	$17.4M	Buy	+60,000	New	+$5.87M	2.04%	20
2020 Q1	–	Sell	-27,279	Closed	-$2.48M	–	49
2019 Q4	$2.48M	Buy	+27,279	New	+$2.65M	0.61%	33

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Logos Global Management's MDGL Position: Q1 2026 in Review

Logos Global Management opened a new position in Madrigal Pharmaceuticals (MDGL) in Q1 2026: 85,000 shares worth $44.5M. The stake represents 2.22% of the portfolio and ranks #13 among its holdings. This is a return to the name: Logos Global Management previously reported a position in MDGL as recently as Q2 2025.

Logos Global Management first reported a position in MDGL in Q4 2019 and has held it in 5 quarters since. 378 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

Logos Global Management held 85,000 shares of Madrigal Pharmaceuticals worth $44.5M as of Q1 2026.
Madrigal Pharmaceuticals was a new Logos Global Management position in Q1 2026.
Madrigal Pharmaceuticals made up 2.22% of Logos Global Management's portfolio in Q1 2026, its #13 holding.
Logos Global Management first reported a position in Madrigal Pharmaceuticals in Q4 2019 and has held it in 5 quarters since.
378 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on Logos Global Management's 13F filing for Q1 2026, filed 15 May 2026.